- Home
- NVCR vs MGNI Comparison
NVCR vs MGNI Comparison
Compare NVCR & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- MGNI
- Stock Information
- Founded
- NVCR 2000
- MGNI 2007
- Country
- NVCR Switzerland
- MGNI United States
- Employees
- NVCR N/A
- MGNI N/A
- Industry
- NVCR Medical/Dental Instruments
- MGNI Computer Software: Programming Data Processing
- Sector
- NVCR Health Care
- MGNI Technology
- Exchange
- NVCR Nasdaq
- MGNI Nasdaq
- Market Cap
- NVCR 1.4B
- MGNI 3.1B
- IPO Year
- NVCR 2015
- MGNI N/A
- Fundamental
- Price
- NVCR $13.05
- MGNI $23.85
- Analyst Decision
- NVCR Buy
- MGNI Strong Buy
- Analyst Count
- NVCR 7
- MGNI 12
- Target Price
- NVCR $28.79
- MGNI $25.75
- AVG Volume (30 Days)
- NVCR 1.4M
- MGNI 3.0M
- Earning Date
- NVCR 10-29-2025
- MGNI 11-06-2025
- Dividend Yield
- NVCR N/A
- MGNI N/A
- EPS Growth
- NVCR N/A
- MGNI N/A
- EPS
- NVCR N/A
- MGNI 0.29
- Revenue
- NVCR $630,160,000.00
- MGNI $685,074,000.00
- Revenue This Year
- NVCR $6.68
- MGNI $3.71
- Revenue Next Year
- NVCR $7.01
- MGNI $12.33
- P/E Ratio
- NVCR N/A
- MGNI $84.61
- Revenue Growth
- NVCR 14.58
- MGNI 5.52
- 52 Week Low
- NVCR $10.87
- MGNI $8.22
- 52 Week High
- NVCR $34.13
- MGNI $26.65
- Technical
- Relative Strength Index (RSI)
- NVCR 56.55
- MGNI 49.46
- Support Level
- NVCR $12.53
- MGNI $22.23
- Resistance Level
- NVCR $13.24
- MGNI $24.20
- Average True Range (ATR)
- NVCR 0.59
- MGNI 1.19
- MACD
- NVCR 0.15
- MGNI -0.22
- Stochastic Oscillator
- NVCR 67.35
- MGNI 37.50
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About MGNI Magnite Inc.
Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.